Itopride structure
|
Common Name | Itopride | ||
---|---|---|---|---|
CAS Number | 122898-67-3 | Molecular Weight | 358.431 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 510.1±50.0 °C at 760 mmHg | |
Molecular Formula | C20H26N2O4 | Melting Point | 185-187 °C(lit.) | |
MSDS | N/A | Flash Point | 262.3±30.1 °C |
Use of ItoprideItopride (HSR803 free base) is a potent and orally active dopamine-2 antagonist and an acetylcholine esterase (AChE) inhibitor. Itopride enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions, can be used as a gastrointestinal prokinetic agent. Itopride can be used for researching gastro-esophageal reflux disease (GERD)[1]. |
Name | N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxybenzamide |
---|---|
Synonym | More Synonyms |
Description | Itopride (HSR803 free base) is a potent and orally active dopamine-2 antagonist and an acetylcholine esterase (AChE) inhibitor. Itopride enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions, can be used as a gastrointestinal prokinetic agent. Itopride can be used for researching gastro-esophageal reflux disease (GERD)[1]. |
---|---|
Related Catalog | |
Target |
D2 Receptor Acetylcholinesterase |
In Vitro | Itopride has prokinetic effects on both the ileum and colon, which are regulated through inhibitory effects on AChE and antagonistic effects on dopamine D2 receptor[3]. Itopride hydrochloride (0.1 nM-1 μM) significantly accelerats the propagation velocity of the peristalsis in ex guinea pig ileum[3]. |
In Vivo | Itopride (30 mg/kg; p.o.) significantly accelerates gastric emptying compared with the vehicle group[4]. Itopride (30 mg/kg; p.o.) displays Cmax of 358 ‰, T1/2 of 24.9 min[4]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 510.1±50.0 °C at 760 mmHg |
Melting Point | 185-187 °C(lit.) |
Molecular Formula | C20H26N2O4 |
Molecular Weight | 358.431 |
Flash Point | 262.3±30.1 °C |
Exact Mass | 358.189270 |
PSA | 60.03000 |
LogP | 2.43 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.552 |
Water Solubility | 18 g/100 mL (20 ºC) |
~79% Itopride CAS#:122898-67-3 |
Literature: CADILA PHARMACEUTICALS LTD. Patent: US2009/177008 A1, 2009 ; Location in patent: Page/Page column 3-4 ; |
~75% Itopride CAS#:122898-67-3 |
Literature: Nielsen, Simon D.; Smith, Garrick; Begtrup, Mikael; Kristensen, Jesper L. Chemistry - A European Journal, 2010 , vol. 16, # 15 p. 4557 - 4566 |
~% Itopride CAS#:122898-67-3 |
Literature: Hermange, Philippe; Lindhardt, Anders T.; Taaning, Rolf H.; Bjerglund, Klaus; Lupp, Daniel; Skrydstrup, Troels Journal of the American Chemical Society, 2011 , vol. 133, # 15 p. 6061 - 6071 |
~% Itopride CAS#:122898-67-3 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 40, # 1 p. 202 - 211 |
~% Itopride CAS#:122898-67-3 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 40, # 1 p. 202 - 211 |
Precursor 8 | |
---|---|
DownStream 1 | |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
MFCD00867431 |
Itopride |
Itopride (INN) |
UNII-81BMQ80QRL |
N-<4-<2-(dimethylamino)ethoxy>benzyl>-3,4-dimethoxybenzamide |
Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxy- |
Ganaton |
[125I]-Itopride |
N-{4-[2-(Dimethylamino)ethoxy]benzyl}-3,4-dimethoxybenzamide |